News

Regeneron's Eylea HD, Odronextamab Applications Hit FDA Snag
The FDA had set an Aug. 19 target action date for the company's application, which was seeking a green light for Eylea HD for the treatment of macular edema following retinal vein occlusion and for ...
South Korea’s new tax proposals derail one of the world’s best performing stock markets of 2025.
After a tumultuous 2024, South Korea’s stock market has enjoyed a banner year, shrugging off the political volatility and the ...
Dominion Energy 2Q Profit, Revenue Increases
Dominion Energy reported a jump in profit despite higher costs in its latest quarter, while also noting a rise in revenue. The electric-services company recorded net income of $760 million, or 88 ...
LyondellBasell 2Q Profit Down on Lower Sales
LyondellBasell Industries recorded a smaller profit in the second quarter on a lower base of sales as it looks to reshape its asset portfolio. The chemicals company on Friday posted a profit of $115 ...
Church & Dwight Posts Lower 2Q Profit, Sales
Church & Dwight logged lower profit and sales in the second quarter, but the drops weren't as steep as Wall Street had predicted and the company noted some improvements throughout the period.
We’ve seen how stocks react to White House pressure for low interest rates and a weak dollar — in October 1987
The financial-market environment now is disturbingly similar to conditions preceding the 1987 stock market crash.
EchoStar Picks MDA Space for Next Satellite Endeavor
EchoStar selected MDA Space as the prime connector for its new satellite constellation. The Englewood, Colo., owner of Dish TV and Boost Mobile on Friday said it chose MDA Space for its new ...
Telus Selling Stake in Canadian Cell Towers; Swings to Quarterly Loss
Telus will sell a minority stake in its Canadian cellphone tower network to one of the country's largest pension funds for 1.26 billion Canadian dollars, the equivalent of $909 million, as the ...
Moderna Says U.K. Court Rules in Favor of its EP'949 Patent, Affirms Infringement by Pfizer and BioNTech -- Update
The biotechnology company on Friday said the U.K. Court of Appeal upheld the validity of its EP'949 patent. It noted the decision affirms the court's initial ruling from July 2024 that the patent is ...
Colgate-Palmolive Aims to Bolster Productivity as 2Q Profit, Revenue Rise
Separately, Colgate-Palmolive disclosed a three-year productivity program, which the company said will better align its organizational structure, optimize its global supply chain and streamline its ...
Regeneron 2Q Revenue, Adjusted EPS Top Estimates
Sales of EYLEA HD rose to $393 million from $304 million a year earlier thanks to increased demand. EYLEA sales, meanwhile, declined to $754 million from $1.23 billion, which the company attributed to ...
July jobs report: Will the labor market weaken enough to spur Fed rate cut?
Fed Chair Jerome Powell said the data will decide whether the central bank can cut rates in September. So all eyes will be on ...